REAL-WORLD OUTCOMES AMONG PATIENTS WHO INITIATED PAZOPANIB OR SUNITINIB AS FIRST TARGETED THERAPY FOR ADVANCED RENAL CELL CARCINOMA (ARCC): A RETROSPECTIVE ANALYSIS OF MEDICARE DATA
Vogelzang, NJ, Ghate, SR, Li, N, Swallow, E, Peeples, M, Zichlin, ML, Meiselbach, MK, Perez, JR, Agarwal, N
Published in Value in health (01.05.2017)
Published in Value in health (01.05.2017)
Get full text
Journal Article